Watch out for NSAIDs!

Kaibysheva V.O.

Kaibysheva V.O.

National Medical Research Center for Therapy and Preventive Medicine;
Pirogov Russian National Research Medical University

ORCID: 0000-0003-0114-3700

Watch out for NSAIDs!

Authors:

Kaibysheva V.O.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(1‑2): 20‑27

Read: 289 times

Contact the author

Table of contents

To cite this article:

Kaibysheva VO. Watch out for NSAIDs! Non Nocere. New Therapeutic Journal. 2025;(1‑2):20‑27. (In Russ.)

Использование инфографики авторами научных работ

References:

Karamysheva EI. The use of non-steroidal anti-inflammatory agents for the treatment of inflammatory diseases of the dento-maxillofacial complex. Russian Journal of Stomatology. 2011;4(5):55-60. (In Russ.) https://www.mediasphera.ru/issues/rossijskaya-stomatologiya/2011/5/032072-64062011512
Lanas A. A review of the gastrointestinal safety data – a gastroenterologist’s perspective. Rheumatology (Oxford). 2010 May;49 Suppl 2(Suppl 2):3-10. https://doi.org/10.1093/rheumatology/keq058
Ivashkin V.T., Sheptulin A.A., Maev I.V., Baranskaya E.K., Trukhmanov A.S., Lapina T.L. Clinical recommendations of the Russian Gastroenterological Association for the diagnosis and treatment of erosive-ulcerous lesions of the stomach and duodenum caused by nonsteroidal anti-inflammatory drugs. Russian journal of gastroenterology, hepatology, coloproctology. 2014;6:89-94.
Karateev A.E., Nasonov E.L., Ivashkin V.T. et al. Rational use of nonsteroidal anti-inflammatory drugs. Clinical recommendations. Scientific and Practical Rheumatology. 2018;56:1-29. https://doi.org/10.14412/1995-4484-2018-1-29
Maev I.V., Andreev D.N., Dicheva D.T., Partzvania-Vinogradova E.V. Gastropathies induced by nonsteroidal anti-inflammatory drugs: pathogenetically based approaches to prevention and therapy. Pharmateca. 2016;4:49-54.
Bakulin I.G., Avalueva E.B., Bakulina N.V., Serkova M.Yu., Berest D.G., Pavlova E.Yu. NSAIDs gastropathies in clinician’s practice. Therapy. 2024;10(3):153-163 https://doi.org/10.18565/therapy.2024.3.153-163
Huang ES, Strate LL, Ho WW, Lee SS, Chan AT. Long-term use of aspirin and the risk of gastrointestinal bleeding. Am J Med. 2011 May;124(5):426-433. https://doi.org/10.1016/j.amjmed.2010.12.022
Nakashima S, Arai S, Mizuno Y, et al. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:60-66. https://doi.org/10.1111/j.1365-2036.2005.02476.x
Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ. 2000 Nov 11;321(7270):1183-1187. https://doi.org/10.1136/bmj.321.7270.1183
Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O. Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs – a 6-year analysis and comparison with non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2005 Aug 15;22(4):285-289. https://doi.org/10.1111/j.1365-2036.2005.02560.x
Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009 Sep 10;361(11):1045-1057. https://doi.org/10.1056/NEJMoa0904327
Lanas A, García-Rodríguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase 2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006 Dec;55(12):1731-1738. https://doi.org/10.1136/gut.2005.080754
Richter JE, Kahrilas PJ, Johanson J, et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol. 2001 Mar;96(3):656-665. https://doi.org/10.1111/j.1572-0241.2001.03636.x
Bhad ME, Abdul S, Jaiswal SB, Chandewar AV. MUPS Tablets – A Brief Review. International Journal of PharmTech Research. 2010;2(1):847-55.
Scheiman JM, Yeomans ND, Talley NJ, et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX 2 inhibitors. Am J Gastroenterol. 2006 Apr;101(4):701-710. https://doi.org/10.1111/j.1572-0241.2006.00499.x
Scheiman JM, Devereaux PJ, Herlitz J, et al. Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON). Heart. 2011 May;97(10):797-802. https://doi.org/10.1136/hrt.2010.217547
Karateev A.E., Nasonova V.A. Prevalence, structure and risk factors of gastropathies induced by NSAIDs. Russian journal of gastroenterology, hepatology, coloproctology. 2000;10(4):34-38.